Morgan Stanley Names Dr. Reddy's (RDY) 'Long Research Tactical Idea'
Tweet Send to a FriendGet Alerts RDY Hot Sheet
Price: $37.32 -0.45%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade RDY Now!
Traders should watch shares of Dr. Reddy's Labs (NYSE: RDY) as Morgan Stanley just named the stock a "Long Research Tactical Idea."
The stock last traded at $29.70, down 0.77 percent for the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock last traded at $29.70, down 0.77 percent for the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Upgrades Pacific Sunwear of California (PSUN) to Buy
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
- Topeka Capital Starts Diodes (DIOD) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
